This study is designed to fill crucial gaps in knowledge concerning cytosine arabinoside (ara-C) mechanism of action and cytotoxicity.
Our specific aims focus on (1.) utilization of pH-step alkaline elution in conjunction with a cell-free human DNA synthetic system to define more precisely how ara-C interferes with the DNA replicative process in intact human cells, and (2.) determining the biological consequences of ara-C incorporated into DNA in terms of its effects on the recognition of a replication origin in DNA by a known DNA synthesis initiator protein, and on the transcription of messenger RNA. To accomplish the first aim, we will utilize a human multi-protein complex that contains the enzymatic components necessary for DNA replication. This complex has a sedimentation coefficient of 21S, and is fully competent to carry out the cell-free replication of the Simian virus 40 (SV40) genome, provided that the SV40-specific initiator protein, large T-antigen (T-Ag) is present. We will strive to develop this 21S multi-protein complex system into a cell-free model that emulates the DNA synthetic apparatus in the intact cell, thereby facilitating the study of the effects of ara-C on the intricate process of human DNA replication. The validity of the 21S replication complex model to mimic cellular events will be monitored by studies of ara-C effects on DNA synthesis in intact cells, using the pH- step alkaline elution technique. For the second aim, we will use recombinant DNA methods to insert ara-C into selected sites in a defined DNA template. We have selected for this template the well characterized SV40 viral genome, or plasmids containing the SV40 origin of replication, ori. These sites for ara-C insertion include a specific gene (T-Ag), and the replication origin, ori. We will then test the effects of the incorporated ara-C on initiator protein (T-Ag) recognition of ori, on RNA transcription of the T-Ag gene, and on the properties and biologic function of any transcript of T-Ag that may be made from an ara-C containing template. Although these studies utilize a viral gene and DNA template, any effects of ara-C incorporation observed should directly reflect the same consequences of ara-C on biological function in human cancer cells. No one has ever studied the effects of ara-C on these processes in such a direct manner. the information obtained from these studies may contribute substantially to improving ara-C therapy, and in devising new and improved methods for the detection of ara-C resistance in acute leukemia patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA040188-09
Application #
2090142
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1985-07-01
Project End
1995-11-30
Budget Start
1994-12-01
Budget End
1995-11-30
Support Year
9
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Doyle, L A; Yang, W; Rishi, A K et al. (1996) H19 gene overexpression in atypical multidrug-resistant cells associated with expression of a 95-kilodalton membrane glycoprotein. Cancer Res 56:2904-7
Wills, P; Hickey, R; Ross, D et al. (1996) A novel in vitro model system for studying the action of ara-C. Cancer Chemother Pharmacol 38:366-72
Lenehan, P F; Gutierrez, P L; Wagner, J L et al. (1995) Resistance to oxidants associated with elevated catalase activity in HL-60 leukemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorubicin manifested by these cells. Cancer Chemother Pharmacol 35:377-86
Ross, D D; Cuddy, D P (1995) Consequences of 2',2'-difluorodeoxycytidine (gemcitabine) on replicative DNA synthesis in intact HL-60 cells. Semin Oncol 22:26-34
Ross, D D; Wooten, P J; Tong, Y et al. (1994) Synergistic reversal of multidrug-resistance phenotype in acute myeloid leukemia cells by cyclosporin A and cremophor EL. Blood 83:1337-47
Ross, D D; Cuddy, D P (1994) Molecular effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on DNA replication in intact HL-60 cells. Biochem Pharmacol 48:1619-30
Ross, D D; Wooten, P J; Sridhara, R et al. (1993) Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia. Blood 82:1288-99
Ross, D D; Cuddy, D P; Cohen, N et al. (1992) Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosine. Cancer Chemother Pharmacol 31:61-70
Gervasoni Jr, J E; Fields, S Z; Krishna, S et al. (1991) Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res 51:4955-63
de Valeriola, D L; Ross, D D; Forrest, A et al. (1991) Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugs. Cancer Chemother Pharmacol 29:133-40

Showing the most recent 10 out of 21 publications